Balance between IL-3 and type Iinterferons and their interrelationship with FasL dictates lifespan and effector functions of human basophils

Clin Exp Allergy. 2017 Jan;47(1):71-84. doi: 10.1111/cea.12850. Epub 2016 Dec 2.

Abstract

Background: In contrast to eosinophils and neutrophils, the regulation of the lifespan of human basophils is poorly defined, with the exception of the potent anti-apoptotic effect of IL-3 that also promotes pro-inflammatory effector functions and phenotypic changes. Type I IFNs (IFN-α, IFN-β), which are well known for their anti-viral activities, have the capacity to inhibit allergic inflammation.

Objective: To elucidate whether type I IFNs have the potential to abrogate the lifespan and/or effector functions of human basophils.

Methods: We cultured human basophils, and for comparison, eosinophils and neutrophils, with IL-3, interferons, FasL and TRAIL, alone or in combination, and studied cell survival, effector functions and signalling pathways involved.

Results: Despite an identical pattern of early signalling in basophils, eosinophils and neutrophils in response to different types of interferons, only basophils displayed enhanced apoptosis after type I IFN treatment. IFN-γ prolonged survival of eosinophils but did not affect the lifespan of basophils. IFN-α-mediated apoptosis required STAT1-STAT2 heterodimers and the contribution of constitutive p38 MAPK activity. Whereas the death ligands FasL and TRAIL-induced apoptosis in basophils per se, IFN-α-mediated apoptosis did neither involve autocrine TRAIL signalling nor did it sensitize basophils to FasL-induced apoptosis. However, IFN-α and FasL displayed an additive effect in killing basophils. Interestingly, IL-3, which protected basophils from IFN-α-, TRAIL- or FasL-mediated apoptosis, did not completely block the additive effect of combined IFN-α and FasL treatment. Moreover, we demonstrate that IFN-α suppressed IL-3-induced release of IL-8 and IL-13. In contrast to IFN-α-mediated apoptosis, these inhibitory effects of IFN-α were not dependent on p38 MAPK signalling.

Conclusions and clinical relevance: Our study defines the unique and granulocyte-type-specific inhibitory and pro-apoptotic function of type I IFNs and their cooperation with death ligands in human blood basophils, which may be relevant for the anti-allergic properties of type I IFNs.

Keywords: TRAIL; FasL; IL-3; JAK/STAT pathway; apoptosis; basophils; cytokine and chemokine production; eosinophils; neutrophils; p38 MAPK pathway; survival; type I IFN; type II IFN; type III IFN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / immunology
  • Basophils / immunology*
  • Basophils / metabolism*
  • Cell Survival / drug effects
  • Cytokines / metabolism
  • Fas Ligand Protein / chemistry
  • Fas Ligand Protein / metabolism*
  • Humans
  • Interferon Type I / metabolism*
  • Interferon Type I / pharmacology
  • Interferon-gamma / metabolism
  • Interferon-gamma / pharmacology
  • Interleukin-13 / metabolism*
  • Janus Kinases / metabolism
  • Models, Biological
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • STAT Transcription Factors / metabolism
  • Signal Transduction / drug effects
  • TNF-Related Apoptosis-Inducing Ligand / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Cytokines
  • FASLG protein, human
  • Fas Ligand Protein
  • Interferon Type I
  • Interleukin-13
  • STAT Transcription Factors
  • TNF-Related Apoptosis-Inducing Ligand
  • Interferon-gamma
  • Janus Kinases
  • p38 Mitogen-Activated Protein Kinases